Measuring Ultrasound Guided Skeletal Muscle Mass of Lower Extremity as a Predictor of Post-Operative Length of Stay in Exploratory Gynae-oncology Surgeries

Condition(s) studied

Investigational drug(s) / intervention(s)

Bed Side ultrasound guided muscle mass estimation of lower extremity: Bed Side ultrasound guided muscle mass estimation of psoas major, rectus femoris, vastus intermedius and tibialis anterior.

Study summary

Increased incidence of Gynae-oncological cancer is observed specifically in women above 50 years of age. Sarcopenia (a progressive and generalized loss of skeletal muscle mass, quality, and strength) is considered a reliable indicator of frailty, a poor prognostic factor in these patients. Various frailty scores and measurement of psoas muscle mass are time consuming, can't be done in patients unable to walk and altered mental status. The investigators wanted to evaluate if bedside ultrasound guided skeletal muscle measurement, as a measure of sarcopenia, can be used to predict post operative length of stay.

Eligibility

Primary outcome measure(s)

• Prolonged length of hospital stay — 3 Years
  Length of hospital stay above 3rd Quartile at 9 days

Trial sites (1)

More Tata Medical Center trials in India

Other trials for the same condition